AMGN

Utilizing the sector drilldown feature of the beefed-up Schaeffer's Equity Scorecard tool, I see a handful of biotechnology names that may have been overshadowed by larger issues, such as AMGN, but may have considerable upside potential.

It's A Good Time To Be A Biotech Bull Bernie Schaeffer 2006

Amgen AMGN, $ 64.21 : An aging population and increased use of prescription drugs mean a sunny future for this drug maker, says Loel Fordham of Port St. Lucie, Fla., who reads Scripps Treasure Coast Newspapers.

Picks for New Contest Rachel Louise Ensign 2012

While he had some stock suggestions -- Bally (BYI), Amgen (AMGN) -- he also noted that "the reality that a lot of things you can buy are overbought."

Robert Lenzner: StreetTalk -- Take Your Gains: Smart Guys Are Cashing Out 2009

(IBB) or the First Trust Amex Biotech index fund (FBT), but note they have a lower correlation with AMGN and DNA.

A Savvy Strategy 2007

One final thing to consider: There are two newly established ETFs that resolve this disparity, keeping AMGN at a relatively equal weight with its peers.

It's A Good Time To Be A Biotech Bull Bernie Schaeffer 2006

AMGN won U.S. approval to expand marketing of its bone-strengthening drug Prolia for people using hormone therapy to treat prostate and breast cancer.

unknown title 2011

Amgen AMGN posted adjusted second-quarter profits of 1.37 a share, zipping past estimates of $1.28.

unknown title 2011

AMGN reported adjusted net income of $1.35 per share.

unknown title 2011

Amgen AMGN may be planning to introduce its first-ever dividend, according to a Deutsche Bank ...

Forbes.com: News MarketNewsVideo.com 2011

Amgen AMGN may be planning to introduce its first-ever dividend, according to a Deutsche Bank ...

Forbes.com: News MarketNewsVideo.com 2011